HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Puerarin attenuates severe burn-induced acute myocardial injury in rats.

AbstractBACKGROUND:
Puerarin, the main isoflavone glycoside extracted from the root of Pueraria lobata, is widely prescribed for patients with cardiovascular disorders in China. This study investigates the effect of puerarin on severe burn-induced acute myocardial injury in rats and its underlying mechanisms.
MATERIALS AND METHODS:
Healthy adult Wistar rats were divided into three groups: (1) sham group, sham burn treatment; (2) burn group, third-degree burns over 30% of the total body surface area (TBSA) with lactated Ringer's solution for resuscitation; and (3) burn plus puerarin group, third-degree burns over 30% of TBSA with lactated Ringer's solution containing puerarin for resuscitation. The burned animals were sacrificed at 1, 3, 6, 12, and 24 h after burn injury. Myocardial injury was evaluated by analyzing serum creatine kinase MB fraction (CK-MB) activity and cardiac troponin T (cTNT) level. Changes in cardiomyocyte ultrastructure were also determined using a transmission electron microscope. Tumor necrosis factor (TNF)-α concentration in serum was measured by radioimmunoassay. Cardiac myeloperoxidase (MPO) activity and malondialdehyde (MDA) concentration were measured to determine neutrophil infiltration and oxidative stress in the heart, respectively. The expression of p38 mitogen-activated protein (MAP) kinase in the heart was determined by Western blot analysis.
RESULTS:
After the 30% TBSA full-thickness burn injury, serum CK-MB activities and cTnT levels increased markedly, both of which were significantly decreased by the puerarin treatment. The level of serum TNF-α concentration in burn group at each time-point was obviously higher than those in sham group (1.09±0.09 ng/ml), and it reached the peak value at 12 h post burn. Burn trauma also resulted in worsen ultrastructural condition, elevated MPO activity and MDA content in heart tissue, and a significant activation of cardiac p38 MAP kinase. Administration of puerarin improved the ultrastructural changes in cardiomyocytes, decreased TNF-α concentration in serum as well as suppressed cardiac MPO activity and reduced MDA content, and abolished the activation of p38 MAP kinase in heart tissue after severe burn.
CONCLUSIONS:
These results suggest that puerarin attenuates inflammatory responses, reduces neutrophil infiltration and oxidative stress in the heart, and protects against acute myocardial injury induced by severe burn.
AuthorsSheng Liu, Hong-Bo Ren, Xu-Lin Chen, Fei Wang, Ren-Su Wang, Bo Zhou, Chao Wang, Ye-Xiang Sun, Yong-Jie Wang
JournalBurns : journal of the International Society for Burn Injuries (Burns) Vol. 41 Issue 8 Pg. 1748-1757 (Dec 2015) ISSN: 1879-1409 [Electronic] Netherlands
PMID26514700 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2015 Elsevier Ltd and ISBI. All rights reserved.
Chemical References
  • Isoflavones
  • Troponin T
  • Vasodilator Agents
  • Malondialdehyde
  • Peroxidase
  • p38 Mitogen-Activated Protein Kinases
  • Creatine Kinase, MB Form
  • puerarin
Topics
  • Animals
  • Burns (complications)
  • Creatine Kinase, MB Form (blood, drug effects)
  • Heart (drug effects)
  • Inflammation
  • Isoflavones (pharmacology)
  • Malondialdehyde (metabolism)
  • Myocardial Ischemia (blood, etiology)
  • Myocardium (immunology, metabolism)
  • Neutrophil Infiltration (drug effects)
  • Oxidative Stress (drug effects)
  • Peroxidase (drug effects, metabolism)
  • Rats
  • Rats, Wistar
  • Trauma Severity Indices
  • Troponin T (blood, drug effects)
  • Vasodilator Agents (pharmacology)
  • p38 Mitogen-Activated Protein Kinases (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: